vida: extract claims from 2023-02-00-pmc-cost-effectiveness-homecare-systematic-review #361
8 changed files with 182 additions and 1 deletions
|
|
@ -17,6 +17,12 @@ This inverts the current clinical paradigm. Instead of patients visiting doctors
|
||||||
|
|
||||||
The wearable medical device market is $48.3B (2025) growing to ~$100B by 2030 at 15.6% CAGR. The broader digital health market is projected at $180B by 2031.
|
The wearable medical device market is $48.3B (2025) growing to ~$100B by 2030 at 15.6% CAGR. The broader digital health market is projected at $180B by 2031.
|
||||||
|
|
||||||
|
|
||||||
|
### Additional Evidence (confirm)
|
||||||
|
*Source: [[2023-02-00-pmc-cost-effectiveness-homecare-systematic-review]] | Added: 2026-03-11 | Extractor: anthropic/claude-sonnet-4.5*
|
||||||
|
|
||||||
|
Market deployment data confirms the technical architecture claim. RPM market growing from $28.9B (2024) to $138B (2033) at 19% CAGR, with home healthcare as the fastest segment at 25.3% CAGR. AI in RPM growing from $1.96B (2024) to $8.43B (2030) at 27.5% CAGR. 71 million Americans expected to use RPM by 2025. This is not speculative technology—this is infrastructure-scale deployment of the multi-layer sensor stack with AI middleware processing.
|
||||||
|
|
||||||
---
|
---
|
||||||
|
|
||||||
Relevant Notes:
|
Relevant Notes:
|
||||||
|
|
|
||||||
|
|
@ -34,6 +34,12 @@ The three-layer model for the healthcare attractor state:
|
||||||
|
|
||||||
Since [[continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware]], the wearable sensor stack represents another tier of atoms-to-bits conversion infrastructure. Since [[Devoteds atoms-plus-bits moat combines physical care delivery with AI software creating defensibility that pure technology or pure healthcare companies cannot replicate]], Devoted is the fullest expression of this thesis at the care delivery level.
|
Since [[continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware]], the wearable sensor stack represents another tier of atoms-to-bits conversion infrastructure. Since [[Devoteds atoms-plus-bits moat combines physical care delivery with AI software creating defensibility that pure technology or pure healthcare companies cannot replicate]], Devoted is the fullest expression of this thesis at the care delivery level.
|
||||||
|
|
||||||
|
|
||||||
|
### Additional Evidence (confirm)
|
||||||
|
*Source: [[2023-02-00-pmc-cost-effectiveness-homecare-systematic-review]] | Added: 2026-03-11 | Extractor: anthropic/claude-sonnet-4.5*
|
||||||
|
|
||||||
|
Home health as the fastest-growing RPM segment (25.3% CAGR) demonstrates that atoms-to-bits conversion happens most effectively in the home setting, not in institutional care. The $265B shift to home care by 2025 is driven by the combination of physical care delivery (atoms) generating continuous monitoring data (bits) that AI processes into clinical insights. This is the defensible layer in deployment—home health companies control the physical touchpoint that generates the data moat.
|
||||||
|
|
||||||
---
|
---
|
||||||
|
|
||||||
Relevant Notes:
|
Relevant Notes:
|
||||||
|
|
|
||||||
|
|
@ -0,0 +1,43 @@
|
||||||
|
---
|
||||||
|
type: claim
|
||||||
|
domain: health
|
||||||
|
description: "Heart failure home care demonstrates 52% cost reduction vs hospital treatment with $15K+ annual savings per patient, indicating home-based delivery operates at a fundamentally different cost structure than institutional care"
|
||||||
|
confidence: likely
|
||||||
|
source: "PMC systematic review of homecare cost-effectiveness studies, 2023"
|
||||||
|
created: 2025-01-11
|
||||||
|
enrichments: []
|
||||||
|
depends_on:
|
||||||
|
- "continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware"
|
||||||
|
---
|
||||||
|
|
||||||
|
# Home health care costs 52 percent less than hospital care for heart failure patients making home-based delivery the structural cost winner
|
||||||
|
|
||||||
|
Home health interventions demonstrate a fundamentally different cost structure than institutional care, not marginal efficiency gains. A systematic review of cost-effectiveness studies found heart failure patients receiving home care incurred costs **52% lower** than traditional hospital treatments. Across multiple conditions, potential savings exceed **$15,000 per patient per year** compared to facility-based care.
|
||||||
|
|
||||||
|
When homecare was compared directly to hospital care across studies, the results showed: cost-saving in 7 studies, cost-effective in 2, and more effective in 1. This is not a mixed picture—it's overwhelming evidence that home-based delivery operates at a lower cost point while maintaining or improving outcomes.
|
||||||
|
|
||||||
|
The economic advantage aligns with patient preference: **94% of Medicare beneficiaries** prefer post-hospital care at home versus nursing homes. This convergence of cost advantage and demand preference creates the conditions for structural market shift.
|
||||||
|
|
||||||
|
Projections indicate up to **$265 billion** in care services for Medicare beneficiaries will shift to home care by 2025. The home healthcare segment is the fastest-growing end-use in the remote patient monitoring market, expanding at 25.3% CAGR through 2033.
|
||||||
|
|
||||||
|
## Evidence
|
||||||
|
|
||||||
|
- Systematic review comparing homecare to hospital care across multiple studies (PMC, 2023)
|
||||||
|
- Heart failure home care cost data: 52% reduction vs hospital treatment
|
||||||
|
- Medicare beneficiary preference data: 94% prefer home vs nursing home post-hospital care
|
||||||
|
- Market shift projection: $265B in Medicare services moving to home by 2025
|
||||||
|
- RPM market growth: home healthcare segment at 25.3% CAGR through 2033
|
||||||
|
|
||||||
|
## Mechanism
|
||||||
|
|
||||||
|
The cost differential is structural, not operational. Home-based care eliminates facility overhead, reduces acute intervention rates through continuous monitoring, and shifts labor from credentialed clinical staff to a mix of technology and lower-cost care coordination. [[continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware]] provides the technology foundation that makes home-based clinical care viable at scale.
|
||||||
|
|
||||||
|
---
|
||||||
|
|
||||||
|
Relevant Notes:
|
||||||
|
- [[continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware]]
|
||||||
|
- [[the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness]]
|
||||||
|
- [[healthcares defensible layer is where atoms become bits because physical-to-digital conversion generates the data that powers AI care while building patient trust that software alone cannot create]]
|
||||||
|
|
||||||
|
Topics:
|
||||||
|
- [[domains/health/_map]]
|
||||||
|
|
@ -0,0 +1,49 @@
|
||||||
|
---
|
||||||
|
type: claim
|
||||||
|
domain: health
|
||||||
|
description: "RPM market quintuples by 2033 with home healthcare adoption outpacing all other segments, indicating infrastructure-scale deployment of continuous monitoring technology"
|
||||||
|
confidence: experimental
|
||||||
|
source: "PMC systematic review citing RPM market projections, 2023"
|
||||||
|
created: 2025-01-11
|
||||||
|
enrichments: []
|
||||||
|
depends_on:
|
||||||
|
- "continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware"
|
||||||
|
---
|
||||||
|
|
||||||
|
# Remote patient monitoring market grows from 28.9 billion in 2024 to 138 billion in 2033 at 19 percent CAGR with home healthcare as fastest segment at 25.3 percent CAGR
|
||||||
|
|
||||||
|
The remote patient monitoring market is projected to grow from $28.9B (2024) to $138B (2033), representing a 19% compound annual growth rate. Within this expansion, home healthcare is the fastest-growing end-use segment at 25.3% CAGR through 2033.
|
||||||
|
|
||||||
|
This growth rate differential matters. Home healthcare RPM is not just participating in market expansion—it's driving it. The 6+ percentage point CAGR advantage over the overall market indicates home-based monitoring is capturing share from institutional settings, not merely growing alongside them.
|
||||||
|
|
||||||
|
AI integration accelerates this trajectory. AI in RPM is projected to grow from $1.96B (2024) to $8.43B (2030) at 27.5% CAGR. The AI layer is what makes continuous home monitoring clinically actionable—[[AI middleware bridges consumer wearable data to clinical utility because continuous data is too voluminous for direct clinician review]].
|
||||||
|
|
||||||
|
By 2025, 71 million Americans are expected to use some form of RPM. This is not niche adoption. This is RPM becoming infrastructure.
|
||||||
|
|
||||||
|
## Evidence
|
||||||
|
|
||||||
|
- RPM market size: $28.9B (2024) → $138B (2033), 19% CAGR (PMC systematic review, 2023)
|
||||||
|
- Home healthcare RPM segment: 25.3% CAGR through 2033 (fastest-growing segment)
|
||||||
|
- AI in RPM: $1.96B (2024) → $8.43B (2030), 27.5% CAGR
|
||||||
|
- Projected RPM users: 71 million Americans by 2025
|
||||||
|
|
||||||
|
## Technology Enablement
|
||||||
|
|
||||||
|
[[continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware]] describes the technical architecture. This market growth data shows the economic deployment of that architecture at scale.
|
||||||
|
|
||||||
|
The 25.3% CAGR for home healthcare RPM is faster than:
|
||||||
|
- Overall RPM market (19%)
|
||||||
|
- AI in RPM (27.5%, but from much smaller base)
|
||||||
|
- Most digital health categories
|
||||||
|
|
||||||
|
This indicates home-based monitoring has crossed the threshold from "emerging technology" to "infrastructure deployment."
|
||||||
|
|
||||||
|
---
|
||||||
|
|
||||||
|
Relevant Notes:
|
||||||
|
- [[continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware]]
|
||||||
|
- [[AI middleware bridges consumer wearable data to clinical utility because continuous data is too voluminous for direct clinician review]]
|
||||||
|
- [[healthcares defensible layer is where atoms become bits because physical-to-digital conversion generates the data that powers AI care while building patient trust that software alone cannot create]]
|
||||||
|
|
||||||
|
Topics:
|
||||||
|
- [[domains/health/_map]]
|
||||||
|
|
@ -0,0 +1,46 @@
|
||||||
|
---
|
||||||
|
type: claim
|
||||||
|
domain: health
|
||||||
|
secondary_domains:
|
||||||
|
- internet-finance
|
||||||
|
description: "SNF profitability splits into winners and losers rather than uniform decline, signaling care delivery model transition"
|
||||||
|
confidence: experimental
|
||||||
|
source: "PMC systematic review citing SNF margin data, 2023"
|
||||||
|
created: 2025-01-11
|
||||||
|
enrichments: []
|
||||||
|
---
|
||||||
|
|
||||||
|
# Skilled nursing facility margin distribution shows bifurcation with 36 percent below negative 4 percent and 34 percent above 4 percent indicating structural transition not uniform decline
|
||||||
|
|
||||||
|
The skilled nursing facility sector exhibits a bimodal margin distribution: 36% of SNFs operate at margins of -4.0% or worse, while 34% maintain margins of 4% or better. This is not a sector in uniform decline—it's an industry undergoing structural separation between winners and losers.
|
||||||
|
|
||||||
|
Bimodal distributions are the signature of transition states. When an industry faces structural change, incumbents split into those who adapt to the new model and those who cannot. The middle collapses. A third of SNFs deeply unprofitable while a third remain profitable suggests the profitable cohort has aligned with value-based care models, integrated with home health delivery, or serves specific high-acuity niches that institutional care still dominates.
|
||||||
|
|
||||||
|
This pattern contradicts the narrative that "SNFs are dying." Instead, SNFs are bifurcating. The question is not whether facility-based post-acute care survives, but which facilities survive and under what business model.
|
||||||
|
|
||||||
|
The margin divergence coincides with the broader shift toward home-based care delivery. Hospital-at-home and home health models are capturing volume from institutional settings, but not uniformly. SNFs that remain profitable likely serve patients for whom home care is not yet viable—complex medical needs, lack of home support infrastructure, or conditions requiring 24-hour monitoring that RPM cannot yet replace.
|
||||||
|
|
||||||
|
## Evidence
|
||||||
|
|
||||||
|
- SNF margin distribution: 36% at -4.0% or worse, 34% at 4%+ (PMC systematic review, 2023)
|
||||||
|
- Care delivery shift: up to $265B in Medicare services projected to move to home care by 2025
|
||||||
|
- Hospital-at-home and home health models capturing institutional volume
|
||||||
|
|
||||||
|
## Interpretation
|
||||||
|
|
||||||
|
The bifurcation pattern suggests the profitable SNF cohort has found defensible positions in the emerging care delivery architecture. These are likely:
|
||||||
|
1. High-acuity patients requiring 24-hour clinical oversight beyond current RPM capabilities
|
||||||
|
2. Integration with value-based care contracts where SNFs serve as step-down from hospital to home
|
||||||
|
3. Geographic markets where home health infrastructure is underdeveloped
|
||||||
|
|
||||||
|
The unprofitable cohort is caught in the worst position: fee-for-service reimbursement declining, volume shifting to home, and no strategic repositioning.
|
||||||
|
|
||||||
|
---
|
||||||
|
|
||||||
|
Relevant Notes:
|
||||||
|
- [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]]
|
||||||
|
- [[the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness]]
|
||||||
|
- [[proxy inertia is the most reliable predictor of incumbent failure because current profitability rationally discourages pursuit of viable futures]]
|
||||||
|
|
||||||
|
Topics:
|
||||||
|
- [[domains/health/_map]]
|
||||||
|
|
@ -285,6 +285,12 @@ Healthcare is the clearest case study for TeleoHumanity's thesis: purpose-driven
|
||||||
|
|
||||||
PACE provides the most comprehensive real-world test of the prevention-first attractor model: 100% capitation, fully integrated medical/social/psychiatric care, continuous monitoring of a nursing-home-eligible population, and 8-year longitudinal data (2006-2011). Yet the ASPE/HHS evaluation reveals that PACE does NOT reduce total costs—Medicare capitation rates are equivalent to FFS overall (with lower costs only in the first 6 months post-enrollment), while Medicaid costs are significantly HIGHER under PACE. The value is in restructuring care (community vs. institution, chronic vs. acute) and quality improvements (significantly lower nursing home utilization across all measures, some evidence of lower mortality), not in cost savings. This directly challenges the assumption that prevention-first, integrated care inherently 'profits from health' in an economic sense. The 'flywheel' may be clinical and social value, not financial ROI. If the attractor state requires economic efficiency to be sustainable, PACE suggests it may not be achievable through care integration alone.
|
PACE provides the most comprehensive real-world test of the prevention-first attractor model: 100% capitation, fully integrated medical/social/psychiatric care, continuous monitoring of a nursing-home-eligible population, and 8-year longitudinal data (2006-2011). Yet the ASPE/HHS evaluation reveals that PACE does NOT reduce total costs—Medicare capitation rates are equivalent to FFS overall (with lower costs only in the first 6 months post-enrollment), while Medicaid costs are significantly HIGHER under PACE. The value is in restructuring care (community vs. institution, chronic vs. acute) and quality improvements (significantly lower nursing home utilization across all measures, some evidence of lower mortality), not in cost savings. This directly challenges the assumption that prevention-first, integrated care inherently 'profits from health' in an economic sense. The 'flywheel' may be clinical and social value, not financial ROI. If the attractor state requires economic efficiency to be sustainable, PACE suggests it may not be achievable through care integration alone.
|
||||||
|
|
||||||
|
|
||||||
|
### Additional Evidence (confirm)
|
||||||
|
*Source: [[2023-02-00-pmc-cost-effectiveness-homecare-systematic-review]] | Added: 2026-03-11 | Extractor: anthropic/claude-sonnet-4.5*
|
||||||
|
|
||||||
|
Home health cost structure provides the economic foundation for the attractor state. Heart failure home care costs 52% less than hospital treatment, with potential savings exceeding $15K per patient per year vs facility-based care. 94% of Medicare beneficiaries prefer home vs nursing home post-hospital care. Up to $265B in Medicare services projected to shift to home by 2025. The cost advantage + patient preference + technology enablement (RPM at 25.3% CAGR) creates the conditions for the prevention-first flywheel to become economically dominant.
|
||||||
|
|
||||||
---
|
---
|
||||||
|
|
||||||
Relevant Notes:
|
Relevant Notes:
|
||||||
|
|
|
||||||
|
|
@ -23,6 +23,12 @@ The Making Care Primary model's termination in June 2025 (after just 12 months,
|
||||||
|
|
||||||
PACE represents the extreme end of value-based care alignment—100% capitation with full financial risk for a nursing-home-eligible population. The ASPE/HHS evaluation shows that even under complete payment alignment, PACE does not reduce total costs but redistributes them (lower Medicare acute costs in early months, higher Medicaid chronic costs overall). This suggests that the 'payment boundary' stall may not be primarily a problem of insufficient risk-bearing. Rather, the economic case for value-based care may rest on quality/preference improvements rather than cost reduction. PACE's 'stall' is not at the payment boundary—it's at the cost-savings promise. The implication: value-based care may require a different success metric (outcome quality, institutionalization avoidance, mortality reduction) than the current cost-reduction narrative assumes.
|
PACE represents the extreme end of value-based care alignment—100% capitation with full financial risk for a nursing-home-eligible population. The ASPE/HHS evaluation shows that even under complete payment alignment, PACE does not reduce total costs but redistributes them (lower Medicare acute costs in early months, higher Medicaid chronic costs overall). This suggests that the 'payment boundary' stall may not be primarily a problem of insufficient risk-bearing. Rather, the economic case for value-based care may rest on quality/preference improvements rather than cost reduction. PACE's 'stall' is not at the payment boundary—it's at the cost-savings promise. The implication: value-based care may require a different success metric (outcome quality, institutionalization avoidance, mortality reduction) than the current cost-reduction narrative assumes.
|
||||||
|
|
||||||
|
|
||||||
|
### Additional Evidence (extend)
|
||||||
|
*Source: [[2023-02-00-pmc-cost-effectiveness-homecare-systematic-review]] | Added: 2026-03-11 | Extractor: anthropic/claude-sonnet-4.5*
|
||||||
|
|
||||||
|
SNF margin bifurcation (36% below -4%, 34% above 4%) demonstrates the payment boundary in action at the provider level. Profitable SNFs have aligned with value-based models or integrated with home health delivery; unprofitable SNFs remain trapped in fee-for-service reimbursement. The bimodal distribution is the signature of partial transition—not all providers have crossed the payment boundary, and those that haven't face structural decline. This extends the payment boundary concept from payer-level analysis to provider-level survival dynamics.
|
||||||
|
|
||||||
---
|
---
|
||||||
|
|
||||||
Relevant Notes:
|
Relevant Notes:
|
||||||
|
|
|
||||||
|
|
@ -7,9 +7,15 @@ date: 2023-02-01
|
||||||
domain: health
|
domain: health
|
||||||
secondary_domains: []
|
secondary_domains: []
|
||||||
format: paper
|
format: paper
|
||||||
status: unprocessed
|
status: processed
|
||||||
priority: high
|
priority: high
|
||||||
tags: [home-health, cost-effectiveness, facility-care, snf, hospital, aging, senior-care]
|
tags: [home-health, cost-effectiveness, facility-care, snf, hospital, aging, senior-care]
|
||||||
|
processed_by: vida
|
||||||
|
processed_date: 2025-01-11
|
||||||
|
claims_extracted: ["home-health-care-costs-52-percent-less-than-hospital-care-for-heart-failure-patients-making-home-based-delivery-the-structural-cost-winner.md", "skilled-nursing-facility-margin-distribution-shows-bifurcation-with-36-percent-below-negative-4-percent-and-34-percent-above-4-percent-indicating-structural-transition-not-uniform-decline.md", "remote-patient-monitoring-market-grows-from-28-9-billion-in-2024-to-138-billion-in-2033-at-19-percent-cagr-with-home-healthcare-as-fastest-segment-at-25-3-percent-cagr.md"]
|
||||||
|
enrichments_applied: ["continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware.md", "the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md", "value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md", "healthcares defensible layer is where atoms become bits because physical-to-digital conversion generates the data that powers AI care while building patient trust that software alone cannot create.md"]
|
||||||
|
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||||
|
extraction_notes: "Three new claims extracted focusing on home health cost advantage, SNF bifurcation as transition indicator, and RPM market growth. Four enrichments applied to existing claims about continuous monitoring, healthcare attractor state, value-based care payment boundary, and defensible atoms-to-bits layer. The 52% cost reduction for heart failure home care is the strongest single data point—it's not marginal efficiency, it's a different cost structure. SNF bifurcation is the most novel insight—bimodal distributions signal transition states, not uniform decline."
|
||||||
---
|
---
|
||||||
|
|
||||||
## Content
|
## Content
|
||||||
|
|
@ -51,3 +57,16 @@ tags: [home-health, cost-effectiveness, facility-care, snf, hospital, aging, sen
|
||||||
PRIMARY CONNECTION: [[continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware]]
|
PRIMARY CONNECTION: [[continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware]]
|
||||||
WHY ARCHIVED: Fills the care delivery layer gap — KB has claims about insurance/payment structure but not about where care is actually delivered and how that's changing.
|
WHY ARCHIVED: Fills the care delivery layer gap — KB has claims about insurance/payment structure but not about where care is actually delivered and how that's changing.
|
||||||
EXTRACTION HINT: The cost differential (52% for heart failure) is the most extractable finding. Pair with RPM growth data to show the enabling technology layer.
|
EXTRACTION HINT: The cost differential (52% for heart failure) is the most extractable finding. Pair with RPM growth data to show the enabling technology layer.
|
||||||
|
|
||||||
|
|
||||||
|
## Key Facts
|
||||||
|
- Home health interventions typically more cost-efficient than institutional care
|
||||||
|
- Potential savings exceeding $15,000 per patient per year vs facility-based care
|
||||||
|
- Heart failure home care: 52% lower costs than hospital treatment
|
||||||
|
- 94% of Medicare beneficiaries prefer post-hospital care at home vs nursing homes
|
||||||
|
- Up to $265 billion in Medicare services projected to shift to home care by 2025
|
||||||
|
- RPM market: $28.9B (2024) → $138B (2033), 19% CAGR
|
||||||
|
- Home healthcare RPM segment: 25.3% CAGR through 2033
|
||||||
|
- AI in RPM: $1.96B (2024) → $8.43B (2030), 27.5% CAGR
|
||||||
|
- 71 million Americans expected to use RPM by 2025
|
||||||
|
- SNF margin distribution: 36% at -4.0% or worse, 34% at 4%+
|
||||||
|
|
|
||||||
Loading…
Reference in a new issue